Literature DB >> 9880384

Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy.

A Izumihara1, T Ishihara, N Iwamoto, K Yamashita, H Ito.   

Abstract

BACKGROUND AND
PURPOSE: Several recent studies have suggested that neurosurgical procedures are not contraindicated in patients with cerebral amyloid angiopathy (CAA). The purpose of this study was to elucidate the clinical factors influencing the outcome of patients with CAA-related intracerebral hemorrhage (ICH) treated surgically.
METHODS: A total of 50 neurosurgical procedures (42 intracerebral hematoma evacuations, 4 ventriculoperitoneal shunts, 3 ventricular drainages, and 1 brain biopsy) were performed in 37 patients with CAA-related ICH. To ascertain the clinical factors that may influence their postoperative outcome, their clinical data (demographics, medical history, recurrent lobar hemorrhage, radiographic characteristics, multiple lobar hemorrhage, surgical details, and postoperative hemorrhage) were examined retrospectively and subjected to multivariate analysis.
RESULTS: Twenty patients (54%) had a good outcome, and only 4 (11%) died. Parietal hematomas, advanced age (>/=75 years), and intraventricular hemorrhages had significant adverse influence on the postoperative outcome. Clinically significant postoperative hemorrhage requiring evacuation occurred after 2 (5%) of 42 intracerebral hematoma evacuations. Postoperative hemorrhage did not have significant adverse influence on the outcome.
CONCLUSIONS: Neurosurgery can be performed relatively safely in patients with CAA-related ICH, and their postoperative outcome is better than that reported previously. Surgical treatment should be considered for such patients aged <75 years without a parietal hematoma and intraventricular hemorrhage.

Entities:  

Mesh:

Year:  1999        PMID: 9880384     DOI: 10.1161/01.str.30.1.29

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

Review 1.  [Zerebrale Amyloidangiopathie : Cerebral amyloid angiopathy].

Authors:  F Block
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 2.  Intracerebral Hemorrhage Location and Functional Outcomes of Patients: A Systematic Literature Review and Meta-Analysis.

Authors:  Anirudh Sreekrishnan; Jennifer L Dearborn; David M Greer; Fu-Dong Shi; David Y Hwang; Audrey C Leasure; Sonya E Zhou; Emily J Gilmore; Charles C Matouk; Nils H Petersen; Lauren H Sansing; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

Review 3.  Postoperative intracranial haemorrhage: a review.

Authors:  Marc A Seifman; Phillip M Lewis; Jeffrey V Rosenfeld; Peter Y K Hwang
Journal:  Neurosurg Rev       Date:  2011-01-19       Impact factor: 3.042

Review 4.  Imaging features of intracerebral hemorrhage with cerebral amyloid angiopathy: Systematic review and meta-analysis.

Authors:  Neshika Samarasekera; Mark Alexander Rodrigues; Pheng Shiew Toh; Salman Al-Shahi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

5.  Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage.

Authors:  Ren-ya Zhan; Ying Tong; Jian-feng Shen; E Lang; C Preul; R G Hempelmann; H H Hugo; R Buhl; H Barth; H Klinge; H M Mehdorn
Journal:  J Zhejiang Univ Sci       Date:  2004-10

6.  Symptomatic lobar intracerebral haemorrhage preceded by transient focal neurological episodes.

Authors:  Robert Hurford; Andreas Charidimou; David Werring
Journal:  BMJ Case Rep       Date:  2013-05-08

7.  Spontaneous upper limb monoplegia secondary to probable cerebral amyloid angiopathy.

Authors:  Ahmed-Ramadan Sadek; Nandita K Parmar; Norah-Hager Sadek; Sanjana Jaiganesh; Samer Elkhodair; Thiagarajan Jaiganesh
Journal:  Int J Emerg Med       Date:  2012-01-03

8.  Severe Japanese encephalitis with multiple intracranial hemorrhages: A case report.

Authors:  Qiaochan Feng; Qi Chen; Xizhuang Bi; Shaoxia Yu; Jiahui Wang; Xuwen Sun; Chao Ren; Hong Liu; Lina Guan
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.